Clinical Trial Update: A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS [Phase 1]

View source ↗

Summary

Phase 1 study evaluating APL-4098 alone and in combination for adults with acute myeloid leukemia or myelodysplastic syndromes; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myelodysplastic Syndromes with Excess Blasts

Drugs mentioned

• APL-4098

Snippet

Sponsor: Apollo Therapeutics Ltd | Conditions: Acute Myeloid Leukemia Refractory, Myelodysplastic Syndrome Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING